VanEck Biotech Financial Statements From 2010 to 2024
| BBH Etf | MXN 2,248 0.00 0.00% |
Check VanEck Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VanEck Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . VanEck financial statements analysis is a perfect complement when working with VanEck Biotech Valuation or Volatility modules.
VanEck |
VanEck Biotech ETF ETF Price To Earning Analysis
VanEck Biotech's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current VanEck Biotech Price To Earning | 16.72 X |
Most of VanEck Biotech's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VanEck Biotech ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, VanEck Biotech ETF has a Price To Earning of 16.72 times. This is much higher than that of the Market Vectors family and significantly higher than that of the Health category. The price to earning for all Mexico etfs is notably lower than that of the firm.
VanEck Biotech ETF Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Biotech's current stock value. Our valuation model uses many indicators to compare VanEck Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Biotech competition to find correlations between indicators driving VanEck Biotech's intrinsic value. More Info.VanEck Biotech ETF is rated below average in price to earning as compared to similar ETFs. It is fourth largest ETF in price to book as compared to similar ETFs fabricating about 0.17 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Biotech ETF is roughly 6.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value VanEck Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VanEck Biotech's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About VanEck Biotech Financial Statements
VanEck Biotech investors use historical fundamental indicators, such as VanEck Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in VanEck Biotech. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in VanEck Etf
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out the analysis of VanEck Biotech Correlation against competitors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.